TRPV2 and prostate carcinoma: TRPV2 has been implicated in numerous pathophysiological processes, including heart failure and various cancers, with early studies demonstrating that TRPV2 modulators binding to the S4/S5 linker or the VBP can suppress glioblastoma progression or reduce prostate cancer metastasis.12